Target intelligence / Profile preview

RNA, U4 small nuclear 61, pseudogene (RNU4-61P)

Target
RNU4-61P
Molecular classification
Other (pseudogene, small nuclear RNA pseudogene)
01

Overview

RNA, U4 small nuclear 61, pseudogene (RNU4-61P) is annotated as a pseudogene of the U4 small nuclear RNA family[1][4]. U4 small nuclear RNAs (snRNAs) are components of the spliceosome, a complex responsible for pre-mRNA splicing in eukaryotic cells, but pseudogenes such as RNU4-61P are generally considered non-functional genetic elements that do not code for active RNA or protein products[1]. There is no evidence that RNU4-61P is expressed, functional, or involved in disease, therapeutic targeting, or biomarker utility. No clinical or pharmacological relevance is known or described for this locus. Key clarifications: - RNU4-61P is not a protein, enzyme, receptor, or known regulatory RNA with biological activity; it is a pseudogene[1][4]. - The term and gene symbol refer to a specific noncoding RNA pseudogene on the human genome, distinct from the canonical U4 small nuclear RNA genes (such as RNU4-2), which are functional in pre-mRNA splicing[2][3]. - No drugs, mechanisms, or biomarkers are associated with RNU4-61P. This designation is likely to be incorrect as a therapeutic target, as it is a non-functional pseudogene without known druggability, molecular function, or clinical relevance[1][4].

Other names
RNU4-61P

Beyond the preview

Go deeper on RNA, U4 small nuclear 61, pseudogene (RNU4-61P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 61, pseudogene (RNU4-61P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call